Delivery Order SPE2DB20D2104-SPE2DB24FMAVH
Award Date
9/4/24
Potential Completion Date
9/5/24
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award has a ceiling value of $2,076.00 and covers the delivery of Glimepiride 4 mg tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of January 27, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Glimepiride 4 mg tablets. The order, valued at $2,388.72, is a firm fixed-price contract with an ultimate completion date of August 2, 2024. Amerisourcebergen is providing these prescription medications without any set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999, held...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,025.72 contract is for the delivery of Glimepiride 4 mg tablets to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $1,119.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4 mg Glimepiride tablets in 100-count bottles. The contract has an ultimate completion date of January 27, 2025 and is a Firm Fixed Price agreement. Amerisourcebergen is the prime contractor, and the contract is not designated as a set-aside. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $22,462.49, is for the supply of Glimepiride 4 mg tablets in 100-count bottles. The contract has a firm-fixed-price structure and a completion date of September 24, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop...
This is a $4,044.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,542,842 Glimepiride 2 mg tablets in 100-count bottles. The award has an ultimate completion date of November 26, 2024 and was not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Glimepiride 4 mg tablets, a diabetes medication, with a ceiling value of $1,711.76 and a completion date of June 18, 2025. This is a Firm Fixed Price Delivery Order contract, which is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of glimepiride 4 mg tablets. The contract is a delivery order with a firm fixed price of $2,283.44 and a completion date of March 12, 2025. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,626,104 Glimepiride 4 mg tablets. The firm-fixed-price delivery order, valued at $4,039.92, has an ultimate completion date of December 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. government has awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply Glimepiride 4 mg tablets. The contract, valued at $1,343.40, is funded by the Defense Logistics Agency (DLA), a defense agency. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to...